The overwhelming majority of nearly 23,000 comments to the Drug Enforcement Administration oppose the agency's proposal to schedule the active materials in the botanical kratom as controlled substances.
Through Dec. 7, the regulation.gov online portal indicated that 22,902 comments had been received for the proposal, docket DEA-2016-0015